Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500375 | SCV000596488 | likely pathogenic | Early infantile epileptic encephalopathy 10 | 2017-04-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001226527 | SCV001398844 | pathogenic | Early infantile epileptic encephalopathy 12 | 2020-05-29 | criteria provided, single submitter | clinical testing | This variant, c.1221_1223del, results in the deletion of 1 amino acid(s) of the PNKP protein (p.Thr408del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with PNKP-related conditions (PMID: 25728773, 27066567, 30039206, Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 190219). This variant has been reported to affect PNKP protein function (PMID: 27066567). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001268911 | SCV001448160 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000170438 | SCV000218380 | pathogenic | Ataxia-oculomotor apraxia 4 | 2015-03-05 | no assertion criteria provided | literature only | |
Mendelics | RCV000170438 | SCV000222876 | pathogenic | Ataxia-oculomotor apraxia 4 | 2015-04-09 | no assertion criteria provided | clinical testing | |
OMIM | RCV001093540 | SCV001250589 | pathogenic | Charcot-Marie-Tooth disease type 2B2 | 2015-03-05 | no assertion criteria provided | literature only |